{"version":"1.0","provider_name":"","provider_url":"https:\/\/peoplebugs.com","author_name":"Peoplebugs","author_url":"https:\/\/peoplebugs.com\/author\/peoplebugs\/","title":"Aurobindo Pharma\u2019s Rivaroxaban Tablets get U.S FDA nod -","type":"rich","width":600,"height":338,"html":"

Aurobindo Pharma\u2019s Rivaroxaban Tablets get U.S FDA nod<\/a><\/blockquote><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/th-i.thgim.com\/public\/incoming\/18qlsy\/article69444207.ece\/alternates\/LANDSCAPE_1200\/Screenshot%201101.png","thumbnail_width":null,"thumbnail_height":null,"description":"Generic drugmaker Aurobindo Pharma has received final\u00a0approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Rivaroxaban\u00a0Tablets USP, 2.5 mg. The approved product is bioequivalent and therapeutically equivalent to the reference listed drug Xarelto 2.5 mg of Janssen Pharmaceuticals Inc., the Hyderabad-headquartered company said on Saturday.\u00a0 It plans to launch the […]"}